Cardiovascular response to stress and perceived stress is not altered 40 years after hypertensive pregnancies
Hypertension in Pregnancy, Volume 34, Issue 1, Page 116-124, February 2015.
Authors: El-Demiry NM, Maged AM, Gaafar HM, ElAnwary S, Shaltout A, Ibrahim S, El-Didy HM, Elsherbini MM Abstract Objective: To evaluate the diagnostic performance of Doppler sonography of umbilical artery (UA), fetal middle cerebral artery (MCA), ductus venosus (DV) &umbilical vein (UV) for prediction of adverse perinatal outcome.Material and Methods: A prospective cohort study conducted on 60 women diagnosed with preeclampsia with severe features divided into two groups based on adverse perinatal outcome.Results: Statistically Significant differences were demonstrated UA PI (1.28 ± 0.23 vs. 0.96 ± 0.21, P
Conditions: Pregnancy Induced Hypertension; Pregnancy Related Intervention: Sponsor: University of Calgary Active, not recruiting
Publication date: Available online 26 February 2020Source: Pregnancy HypertensionAuthor(s): Mi Zhou, Meng Chen, Huai Bai, Guo-Lin He, Qing-Qing Liu, Lin-Bo Guan, Xing-Hui Liu, Ping Fan
Publication date: Available online 26 February 2020Source: Pregnancy HypertensionAuthor(s): Joana Lopes Perdigao, Adi Hirshberg, Nathanael Koelper, Sindhu K. Srinivas, Mary D. Sammel, Lisa D. Levine
Publication date: Available online 26 February 2020Source: Pregnancy HypertensionAuthor(s): Alexandra Moloney, Michelle Hladunewich, Eden Manly, Dini Hui, Stefania Ronzoni, John Kingdom, Vasilica Stratulat, Arthur Zaltz, Jon Barrett, Nir Melamed
CONCLUSIONS: Postnatal rhIGF-1/IGFBP-3 treatment preserved lung structure and prevented RVH in antenatal and postnatal BPD models. rhIGF-1/BP-3 treatment may provide a novel strategy for the prevention of BPD in preterms. PMID: 32101461 [PubMed - as supplied by publisher]
Publication date: February 2020Source: Trends in Anaesthesia and Critical Care, Volume 30Author(s): Maretha Smit, Leon Du Toit, Carl Lombard, Dominique Van Dyk, Anthony Reed, Robert Dyer, Ross Hofmeyr
TRENTON, N.J. (AP) — U.S. regulators on Friday approved a new type of cholesterol-lowering drug aimed at millions of people who can’t tolerate — or don’t get enough help from — widely used statin pills like Lipitor and Crestor. The Food and Drug Administration approved Esperion Therapeutics Inc.’s Nexletol for people genetically predisposed to have sky-high cholesterol and people who have heart disease and need to further lower their bad cholesterol. The daily pill is to be taken in conjunction with a healthy diet and the highest statin dose patients can handle, the FDA said. High LDL, o...
In conclusion, taller body height at the entry to adulthood, supposed to be a marker of early-life environment, is associated with lower risk of dementia diagnosis later in life. The association persisted when adjusted for educational level and intelligence test scores in young adulthood, suggesting that height is not just acting as an indicator of cognitive reserve. A Comparison of Biological Age Measurement Approaches https://www.fightaging.org/archives/2020/02/a-comparison-of-biological-age-measurement-approaches/ Researchers here assess the performance of a range of approaches to measuring biological...
Authors: Abstract Stillbirth is one of the most common adverse pregnancy outcomes, occurring in 1 in 160 deliveries in the United States. In developed countries, the most prevalent risk factors associated with stillbirth are non-Hispanic black race, nulliparity, advanced maternal age, obesity, preexisting diabetes, chronic hypertension, smoking, alcohol use, having a pregnancy using assisted reproductive technology, multiple gestation, male fetal sex, unmarried status, and past obstetric history. Although some of these factors may be modifiable (such as smoking), many are not. The study of specific causes of stil...